ResearchMoz added Latest Research Report titled " Global Human Respiratory Syncytial Virus Drugs Market 2016-2020: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.

Albany, NY -- (SBWire) -- 12/27/2016 --Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common cold. Infection with RSV can be severe in certain cases, particularly in premature infants and babies with underlying health conditions. RSV can also become serious in the older population or adults with heart and lung diseases, or any individual with a very weak immune system. The global human respiratory syncytial virus drugs market to grow at a CAGR of 4.27% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global human respiratory syncytial virus drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent respiratory syncytial virus infections.

The market is divided into the following segments based on geography:
- Europe
- ROW
- US

Get a Sample Research PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=902730

Technavio's report, Global Human Respiratory Syncytial Virus Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AstraZeneca
- AbbVie
- GSK
- Teva Pharmaceutical

Other prominent vendors
- Ablynx
- ADMA Biologics
- Alnylam Pharmaceuticals
- Ark Biosciences
- Aviragen Therapeutics
- Bavarian Nordic
- Boehringer Ingelheim
- Gilead Sciences
- ImmunoVaccine Technologies
- Johnson & Johnson
- Kyowa Hakko Kirin
- Medivir
- Mucosis
- Mymetics Corporation
- Novavax
- Regeneron Pharmaceuticals
- ReViral
- Vaxart

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=902730

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG